Sudeep Pharma IPO Sees Exceptional Demand, Subscribed 93.71x on Day 3

Sudeep Pharma Limited's initial public offering (IPO) has demonstrated exceptional investor interest through its third day of subscription. The stock price band is set at ₹563-593 per share. The ₹895.00 crore IPO reached 93.71 times by 5:09:33 PM on day three. 

Sudeep Pharma IPO qualified institutional buyers segment leads with exceptional 213.08 times subscription. Non-institutional investors demonstrate exceptional participation at 116.72 times. Retail investors display exceptional interest at 15.65 times. Anchor investors show complete participation at 1.00 times.

Invest in Indian Markets and Unlock Future Potential With 5paisa!

Open Account Now

Sudeep Pharma IPO subscription reached exceptional 93.71 times on day three. It was led by Qualified Institutional Buyers Ex-Anchor (213.08x), Non-Institutional Investors (116.72x), and Retail Investors (15.65x). Total applications reached 29,84,653.

Subscription Status of Sudeep Pharma IPO:

Here are the subscription details for Sudeep Pharma IPO as of Day 3 (November 25, 2025, 5:09:33 PM):

Key Highlights - Day 3:

• Overall subscription reached exceptional 93.71 times, showing extraordinary improvement from day two's 5.13 times
• Qualified institutional buyers (ex-anchor) displaying exceptional interest at 213.08 times, building dramatically from day two's 0.13 times, indicating very strong institutional appetite for this pharmaceutical excipients manufacturer
• Retail investors displaying exceptional confidence at 15.65 times, building substantially from day two's 5.02 times, indicating robust retail demand for this company serving over 100 countries
• Total applications reached 29,84,653, showing exceptional investor participation for this mainboard IPO, a significant increase from day two's 8,76,425 applications
• Cumulative bid amount reached ₹58,711.61 crores, significantly exceeding the net offer size of ₹626.50 crores (excluding anchor portion) by over 93 times
• Anchor investors fully subscribed their allocation of ₹268.50 crores on November 20, 2025
   

Key Highlights - Day 2:

• Overall subscription reached strong 5.13 times, showing substantial improvement from day one's 1.43 times
• Non-institutional investors displaying exceptional interest at 12.03 times, building substantially from day one's 3.01 times
• Retail investors showing strong performance at 5.02 times, building substantially from day one's 1.53 times
• Qualified institutional buyers showing minimal participation at 0.13 times, marginally improving from day one's 0.09 times

Key Highlights - Day 1:

• Overall subscription reached strong 1.43 times, showing robust initial investor interest
• Non-institutional investors displaying moderate confidence at 3.01 times, indicating healthy HNI appetite
• Retail investors showing moderate performance at 1.53 times, indicating positive retail sentiment
• Qualified institutional buyers showing minimal participation at 0.09 times, indicating very weak institutional appetite
   

About Sudeep Pharma Limited

Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries. The company operates six manufacturing facilities with a combined production capacity of 50,000 MT, specialising in minerals such as calcium, iron, magnesium, zinc, potassium, and sodium. The company supplies more than 200 products to a diverse customer base across pharma, food, and nutrition sectors.